Maiwald Magazine

News and Releases

Maiwald Blog

Unitary Patent System: Provisional Application of the Agreement on a Unified Patent Court (UPCA) starts

Yesterday, Austria has deposited its instrument of ratification on the Protocol to the Agreement on a Unified Patent Court on provisional application as the thirteenth member ...

Continue reading

Patent: Suspension of Infringement Proceedings in the Case of (Future) Nullity Suit

Higher Regional Court of Düsseldorf, order of 22 September 2021, Case No. I-2 W 17/21 - Suspension standard Afte...

Continue reading

Possible Referral to the Enlarged Board of Appeal on the Applicability of the “Joint Applicants Approach” (T 1513/17)

Whether a Euro-PCT application validly claims the priority of an ea...

Continue reading

All articles

Press Coverage

Royalty Pharma and Cytokinetics Announce Funding Agreements Totaling up to $450 Million

Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of AficamtenRoyalty Pharma Purchases Royalties on Future Sales of Aficamten

Continue reading

Royalty Pharma Acquires Additional Royalty Interests in bcx9930 and Orladeyo From Biocryst Pharmaceuticals

Royalty Pharma plc (Nasdaq: RPRX), BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) and OMERS Capital Markets (OMERS) today announced transactions totaling $350 million in new funding for BioCryst, with all funds immediately available at closing.

Continue reading

Preparing Clients for the Future

A European Unitary Patent and a Unified Patent Court: The EU aims to create a European Unitary Patent with uniform effect in all member states of the European Union. There are still political and legal debates, but no one doubts that the EU Unitary Patent will come one day.

Continue reading

Maiwald in the press

Staff News

Maiwald Appoints Dr Annelie Wünsche as Partner

Maiwald, one of Germany’s leading IP law firms, has appointed Dr Annelie Wünsche as partner wi...

Continue reading

Maiwald Appoints Three New Counsels

With effect from 1 March 2021, Maiwald Patentanwalts- und Rechtsanwaltsgesellschaft mbH, one of Germany's leading IP firms, appointed three of its Munich patent attorneys to C...

Continue reading

Maiwald appoints Dr. Andreas Eisele as Counsel

Maiwald, one of the leading German patent law firms, has appointed Andreas Eisele, a ...

Continue reading

All Staff News


2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)”

We are delighted to announce the release of the 2nd Edition of the Handbook “The Supplementary Protection Certificates (SPC)” edited by our partner 

Continue reading

JUVE Handbook 2021/2022: Co-publishing article on the topic of “Chances and stumbling blocks in video negotiations at the EPO”

In the current edition of the JUVE Handbook for Commercial Law Firms 2021/2022 published in October 2021

Continue reading

All publications


Wirtschaftswoche: Top Law Firms and Top Attorney 2021

We are very pleased that our law firm was named "TOP Law Firm...

Continue reading

JUVE Patent 2021

Life science sector highlighted Maiwald is again listed as the leading German law firm for patent law in ...

Continue reading

JUVE German Commercial Law Firms 2021/2022

The JUVE Handbook of Commercial Law Firms once again ranks Maiwald among the leading German law firms for patent law and praises our strengths in patent prosecution and proces...

Continue reading

All awards


All events